Citadel Advisors’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-236,500
| Closed | -$20.1M | – | 11879 |
|
|
2020
Q3 | $20.1M | Sell |
236,500
-303,300
| -56% | -$15.3M | 0.01% | 1560 |
|
|
2020
Q2 | $19.1M | Buy |
539,800
+333,400
| +162% | +$9.75M | 0.01% | 1543 |
|
|
2020
Q1 | $2.78M | Sell |
206,400
-520,000
| -72% | -$8.75M | ﹤0.01% | 3582 |
|
|
2019
Q4 | $15.4M | Sell |
726,400
-173,400
| -19% | -$3.06M | 0.01% | 1745 |
|
|
2019
Q3 | $11.9M | Sell |
899,800
-43,600
| -5% | -$641K | 0.01% | 2011 |
|
|
2019
Q2 | $13.1M | Buy |
943,400
+343,900
| +57% | +$5.17M | 0.01% | 1861 |
|
|
2019
Q1 | $11.5M | Buy |
599,500
+148,000
| +33% | +$2.39M | 0.01% | 1904 |
|
|
2018
Q4 | $6.44M | Buy |
451,500
+275,100
| +156% | +$5.46M | ﹤0.01% | 2443 |
|
|
2018
Q3 | $3.67M | Sell |
176,400
-73,100
| -29% | -$1.73M | ﹤0.01% | 3418 |
|
|
2018
Q2 | $5.91M | Buy |
249,500
+86,900
| +53% | +$1.75M | ﹤0.01% | 2544 |
|
|
2018
Q1 | $2.38M | Sell |
162,600
-178,700
| -52% | -$2.92M | ﹤0.01% | 3470 |
|
|
2017
Q4 | $5.51M | Buy |
341,300
+63,100
| +23% | +$745K | ﹤0.01% | 2368 |
|
|
2017
Q3 | $3.89M | Buy |
278,200
+88,500
| +47% | +$882K | ﹤0.01% | 2577 |
|
|
2017
Q2 | $1.68M | Buy |
189,700
+24,300
| +15% | +$171K | ﹤0.01% | 3400 |
|
|
2017
Q1 | $1.07M | Buy |
165,400
+30,700
| +23% | +$156K | ﹤0.01% | 3894 |
|
|
2016
Q4 | $494K | Buy |
134,700
+19,600
| +17% | +$58K | ﹤0.01% | 4913 |
|
|
2016
Q3 | $374K | Buy |
115,100
+18,700
| +19% | +$52.3K | ﹤0.01% | 5322 |
|
|
2016
Q2 | $224K | Buy |
96,400
+66,100
| +218% | +$221K | ﹤0.01% | 5663 |
|
|
2016
Q1 | $76K | Sell |
30,300
-117,500
| -79% | -$264K | ﹤0.01% | 6136 |
|
|
2015
Q4 | $454K | Buy |
147,800
+21,900
| +17% | +$61.1K | ﹤0.01% | 4589 |
|
|
2015
Q3 | $217K | Sell |
125,900
-174,900
| -58% | -$446K | ﹤0.01% | 6042 |
|
|
2015
Q2 | $1.22M | Buy |
300,800
+141,000
| +88% | +$576K | ﹤0.01% | 3713 |
|
|
2015
Q1 | $612K | Buy |
159,800
+47,900
| +43% | +$208K | ﹤0.01% | 4619 |
|
|
2014
Q4 | $537K | Buy |
111,900
+31,700
| +40% | +$125K | ﹤0.01% | 4631 |
|
|
2014
Q3 | $298K | Buy |
80,200
+5,500
| +7% | +$18.6K | ﹤0.01% | 5269 |
|
|
2014
Q2 | $273K | Buy |
74,700
+34,900
| +88% | +$128K | ﹤0.01% | 5180 |
|
|
2014
Q1 | $168K | Sell |
39,800
-50,900
| -56% | -$252K | ﹤0.01% | 5706 |
|
|
2013
Q4 | $417K | Buy |
90,700
+48,900
| +117% | +$218K | ﹤0.01% | 4230 |
|
|
2013
Q3 | $259K | Sell |
41,800
-11,000
| -21% | -$63.3K | ﹤0.01% | 4510 |
|
|
2013
Q2 | $287K | Buy |
+52,800
| New | +$173K | ﹤0.01% | 4346 |
|
Citadel Advisors's IMMU Position: Q4 2020 in Review
Citadel Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,506,602 shares — an estimated $213M sold.
Citadel Advisors first reported a position in IMMU in Q2 2013 and held it in 26 quarters. The position peaked at $213M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Citadel Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Citadel Advisors sold 2,506,602 Immunomedics Inc shares in Q4 2020, an estimated $213M.
- Citadel Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 26 quarters.
- Citadel Advisors's Immunomedics Inc position peaked at $213M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.